BACKGROUND: It is unclear whether treatment delay affects the clinical outcomes of chemotherapy in advanced gastric cancer (A-GC). AIM: To assess whether treatment delay affects the clinical outcomes of chemotherapy in A-GC. METHODS: This single-center retrospective study examined consecutive patients with A-GC between April 2012 and July 2018. In total, 110 patients with stage IV A-GC who underwent chemotherapy were enrolled. We defined the wait time (WT) as the interval between diagnosis and chemotherapy initiation. We evaluated the influence of WT on overall survival (OS). CONCLUSION: A longer WT in patients with A-GC does not appear to be associated with a worse prognosis.
No takes yet. Share an insight, caveat, or question.
Nishida et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: